For example, CD64 might participate in the immunosuppressed environment described in experimental and human studies of Alzheimer’s disease [15, 27] and thus to the impairment of microglial motility. The gene discussed is FCGR1A; the disease is early-onset autosomal dominant Alzheimer disease.